We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Barr Pharmaceuticals is making a change to its Plan B application that should clear the way for the FDA to approve the contraceptive for OTC use, a Barr spokeswoman said.